Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
391 - 400 of 892 results
  • Abstract
    Survival in 4-repeat tauopathies is associated with cerebrospinal fluid phosphorylated tau
    Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Parkinson’s Disease (PD), including PD with mild cognitive impairment (MCI) and dementia, are all characterized by parkinsonian motor features that may additionally include cogni...
    Nov 16, 2016
  • Abstract
    Selective, reversible monoacylglycerol lipase (MGL) inhibitor blocks stimulation of brain prostaglandin E2 (PGE2) and cytokines induced by peripherally dosed lipopolysaccharides (LPS) in mice
    Cannabis Sativa has been used in folk medicine to treat pain, gastrointestinal disturbances, depression and other conditions. Cannabis also has undesirable effects such as memory impairment and hyperphagia. Tetrahydrocannabinol, a psychoactive terpenoid...
    Nov 13, 2016
  • Abstract
    Pathway-specific modulation of lateral habenula GABAergic inputs by acute and chronic cannabinoids
    The lateral habenula (LHb) is a brain region implicated in coordinating behavioral responses to punishment, omission of reward, and other negative environmental stimuli. Moreover, LHb neurons increase their activity during behavioral avoidance and in de...
    Oct 23, 2019
  • Abstract
    A novel technique to study CB1 cannabinoid receptor internalization in cultured hippocampal neurons.
    CB1 cannabinoid receptors are G-protein coupled receptors enriched on presynaptic processes in several central nervous system regions including those that underlie analgesia, cognition, motor control, and memory. CB1 receptors are the primary target of delta-9-tetrahydrocannabinol, (THC) the major psychoactive constituent of cannabis, and are also activated by endogenous cannabinoids. Tolerance develops following chronic THC use and CB1 receptor internalization is a process likely to contribute to tolerance. It is known that following sustained agonist treatment, heterologously expressed CB1 receptors internalize via a classical clathrin-mediated pathway. The aim of this study was to develop and characterize a technique to investigate the kinetics and mechanisms of CB1 internalization in primary hippocampal cultures using immunocytochemistry and confocal microscopy. During brief administration of the synthetic CB1 agonist CP55,940, CB1 staining in boutons became increasingly punctuate. This was quantified ...
    Oct 27, 2004
  • Abstract
    L-DOPA-induced dyskinesia in mice leads to the production of astrocyte-derived TNF-alpha through a glutamate-dependent mechanism
    Here we addressed the hypothesis that L-DOPA-induced dyskinesia (LID) could be favored by the striatal pro-inflammatory environment resulting from abnormal glutamate (GLU) release from the motor cortex induced by L-DOPA dyskinesiogenic treatment. To thi...
    Oct 21, 2019
  • Abstract
    Effects of cannabis use during pregnancy on maternal care and anxiety-like behavior in rats
    The use of cannabis during pregnancy is a growing public health concern. Unfortunately, as the cannabis industry has been rapidly expanding, research on the effects of cannabis use during pregnancy remains limited and the effects of maternal cannabis us...
    Nov 10, 2021
  • Abstract
    Impact of maternal cannabis vapor self-administration on offspring neurodevelopment and anxiety-like behavior
    Cannabis is the most used illicit drug during pregnancy, yet little is known about the lasting impacts of prenatal cannabis exposure on neurodevelopmental endpoints. To address this issue, our laboratory recently used a novel cannabis vapor exposure mod...
    Nov 9, 2021
  • Abstract
    Frontolimbic white matter pathways link prenatal cannabis exposure to child anxiety symptoms
    Some pregnant women use cannabis to assuage symptoms of morning sickness or anxiety, and some cannabis-using women may have not known they were pregnant. However, research shows that approximately 1/3 of cannabis constituents, such as delta-9-tetrahydro...
    Nov 9, 2021
  • Abstract
    Modulation of inhibitory receptors by non-psychoactive cannabinoids
    Glycine and type A γ-aminobutyric acid receptors (GlyRs and GABAARs) are ligand-gated ion channels that mediate fast inhibitory neurotransmission in the nervous system. Direct modulation of GlyRs and GABAARs by a number of cannabinoids has been previous...
    Nov 12, 2016
  • Abstract
    The sigma1 receptor antagonist CM304 enhances the antinociceptive effects of cannabinoid CB1 agonists, but not mu-opioid receptor agonists, in mice
    There is an overdose epidemic associated with the use of illicitly manufactured as well as prescription mu-opioid agonists. Sigma1 receptor (σ1R) antagonists in combination with other drugs may provide a viable, safe pharmacological option for treating ...
    Oct 21, 2019
  • Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience